ClinicalTrials.Veeva

Menu

Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia

R

Real Fundación Victoria Eugenia

Status

Unknown

Conditions

Haemophilia

Treatments

Other: Patients with haemophilia

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02582450
Veritas-Validation

Details and patient eligibility

About

Research project for validation of a questionnaire on compliance to treatment in patients with hemophilia. It is intended to validate the American VERITAS-PRO scale according to the international methodology validation questionnaires: reverse translation, according to intersubject patients, psychometric validation and reliability analysis with large sample of patients.

Full description

The validated questionnaire obtained in this project will identify the actual degree of patient compliance to drug therapy, using as gold standard the difference between the treatment prescribed and administered.

Enrollment

70 estimated patients

Sex

Male

Ages

13 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with hemophilia A and B
  • Patients who have previously signed the informed consent document

Exclusion criteria

  • Patients with other congenital coaghulopatías (eg, Von Willebrand's disease)
  • Patients with cognitive impairment, or oral or written understanding

Trial design

70 participants in 1 patient group

Patients with haemophilia
Description:
Sample of patients with haemophilia over 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the Veritas-Pro questionnaire.
Treatment:
Other: Patients with haemophilia

Trial contacts and locations

1

Loading...

Central trial contact

Ana Torres-Ortuño, PhD; Rubén Cuesta-Barriuso, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems